Enter a Ticker Symbol To Get Your Free Bull/Bear Rating & Ranking Report from "Stock Scientist" Mike Turner

Dividend Quote

ARDS

Aridis Pharmaceuticals Inc

Add to Scorecard

New Report from the Award-winning Analyst Who Beat the Market Over 15 Years

(For Privacy Policy visit us here)
*Note: You will not be spammed, ever. Period.

ARDS:Aridis Pharmaceuticals Inc - Stock Quote and Dividend Data

LATEST CLOSE PRICE

$7.82

EXCHANGE

NASDAQ

SECTOR

Health Care

ARDS
Aridis Pharmaceuticals Inc Dividend Information
Trailing 12 Month Dividend Yield0.00%
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years

Dividend Payment TypeNone
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone

FREE INVESTOR BRIEFING

Collect an 8% Yield on this "Government Mandated Income Opportunity"

(For Privacy Policy visit us here)
*Note: You will not be spammed, ever. Period.
ARDS
Aridis Pharmaceuticals Inc Stock Information
Latest Close Price$7.82
52-Week Low/High$7.59 - $13.85
Percent Held by Institutions0.00%
Revenue$410,000
Net Income$-24,477,000
Cash Flow$-6,270,000
EPS-11.78%
Market Cap$63,372,995
PE Ratio0
PE Ratio to Industry66%
Debt-Equity Ratio0.00%
Debt-Equity to Industry1.39%
Total Return Last 12 Months0.00%
Total Return Last 3 Years0.00%
Total Return Last 5 Years0.00%
Latest Trade DateDec. 11, 2018
ARDS
Aridis Pharmaceuticals Inc Dividend Payment History

No Data available for Payment History.

ARDS
Aridis Pharmaceuticals Inc Other Details

Aridis Pharmaceuticals is a late-stage biopharmaceutical company focused on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections. mAbs represent an innovative treatment approach that harnesses the human immune system to fight infections and are designed to overcome the deficiencies associated with therapies, such as rise in drug resistance, short duration of response, negative impact on the human microbiome, and lack of differentiation among the treatment alternatives. The majority of Co.'s product candidates are derived by employing Co.'s differentiated antibody discovery platform called MabIgX.

Web Sitewww.aridispharma.com
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryPharmaceuticals
Dividend AllStar™ Ranking
Dividend Re-Investment PlanNo
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Dividend Tools

Building a successful dividend income portfolio is simple… if you have the right tools at your disposal. Here’s a sampling of Dividend Investor’s Dividend Tools, used by thousands of investors across the globe to gain a substantial edge in their portfolio strategies.

Dividend AllStar™ Ranking

Find stocks with consecutively increasing dividends:

  • = 5 years of dividend increases
  • = 10 years of dividend increases
  • = 20 years of dividend increases

Click to Learn More

Monthly Dividend Directory

Learn which investments pay out every month, including:

  • Dividend yield
  • Ex-dividend date
  • Dividend payout date… and more

Click to Learn More

Stock Screening Tools

Screen and filter thousands of dividend-paying investments with Dividend Investor’s advanced screening tools:

  • Dividend Payout Ratio
  • Consecutive Increases
  • 5-Year Total Return… and more

Click to Learn More

Try Dividend Investor PREMIUM for as low as $29

  • Dividend Allstars™ Tool
  • Proprietary Ex-dividend Calendar
  • Dividend Scorecard™ Portfolio Tracker
  • Customized Dividend Stock Screener
  • 4 FREE special reports from leading dividend experts
  • And much more...
 
Aridis Pharmaceuticals Inc Dividend Stock News and Updates

Dec. 05, 2018CLOSE PRICE DECREASE: Aridis Pharmaceuticals Inc (NASDAQ: ARDS) on 12-05-2018 decreased close price > 10% from $9.95 to $8.50

Read more...

Dec. 01, 2018CLOSE PRICE DECREASE: Aridis Pharmaceuticals Inc (NASDAQ: ARDS) on 12-01-2018 decreased close price > 10% from $12.40 to $10.60

Read more...
More Aridis Pharmaceuticals Inc Dividend News
Pharmaceuticals Dividend Stock News and Updates

Dec. 12, 201852 WEEK LOW: Aceto Corp (NASDAQ: ACET) on 12-12-2018 hit a 52 week low of $1.45

Read more...

Dec. 12, 2018CLOSE PRICE INCREASE: China BCT Pharmacy Group, Inc. (OTCBB: CNBI) on 12-12-2018 increased close price > 10% from $0.00 to $0.00

Read more...

Dec. 12, 2018CLOSE PRICE INCREASE: Corcept Therapeutics Inc (NASDAQ: CORT) on 12-12-2018 increased close price > 10% from $12.98 to $17.17

Read more...
More Pharmaceuticals Dividend News
FREE REPORT
X
Bryan Perry Dividend Income Expert Bryan Perry

Earn 8% on this "Government Mandated Income Opportunity"

X

Search Dividend Investor